1021 |
CYCLIN DEPENDENT KINASE 6 |
CDK6 |
MCPH12 |
PLSTIRE |
603368 |
1777 |
ENSG00000105810 |
OTTHUMG00000131697 |
CDK 4,6 |
CDK 1,2,4,5,6,7,9 (pan-CDK) |
CELL DIVISION PROTEIN KINASE 6 (EC 2.7.1.37) (SERINE/THREONINE-PROTEIN KINASE PLSTIRE). [SOURCE:UNIPROT/SWISSPROT;ACC:Q00534] |
CDKN6 |
Cyclin-dependent kinase 6 |
Cell division protein kinase 6 |
Serine/threonine-protein kinase PLSTIRE |
Q00534 |
CDK6_HUMAN |
12 |
T89361 |
Human Readable Name | DRUGGABLE GENOME |
Target Class | Enzymes |
Target Subclass | EC:2.7.11.22 |
Interpro Acc | IPR002290 |
Uniprot Status | Swiss-Prot |
Interpro Type | Domain |
Interpro Short Name | Ser/Thr_dual-sp_kinase_dom |
Uniprot Evidence | 1: Evidence at protein level |
Human Readable Name | KINASE |
Interpro Name | Serine/threonine- / dual-specificity protein kinase, catalytic domain |
CancerCommons Reported Gene Name | CDK4/6 |
Gene Biotype | PROTEIN_CODING |
TUMOR SUPPRESSOR |
KINASE |
SERINE THREONINE KINASE |
DRUG RESISTANCE |
DRUGGABLE GENOME |
CLINICALLY ACTIONABLE |
inhibitor (inhibitory) |
Mechanism of Interaction | Cyclin-dependent kinase 6 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Cyclin-dependent kinase 6 inhibitor |
inhibitor (inhibitory) |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Mechanism of Interaction | Cyclin-dependent kinase 6 inhibitor |
Direct Interaction | yes |
Trial Name | LEE011 |
inhibitor (inhibitory) |
inhibitor (inhibitory) |
Reported Cancer Type | Melanoma |
Mechanism of Interaction | Cyclin-dependent kinase 6 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Cyclin-dependent kinase 6 inhibitor |
Direct Interaction | yes |
Trial Name | flavopiridol, alvocidib, HMR-1275 |
inhibitor (inhibitory) |
Reported Cancer Type | Melanoma |
Mechanism of Interaction | CDK6/cyclin D1 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Cyclin-dependent kinase inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Cyclin-dependent kinase 6 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Cyclin-dependent kinase inhibitor |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Cyclin-dependent kinase inhibitor |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Cyclin-dependent kinase inhibitor |
CDK6 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
CDK6 | Uniprot Gene Name |
Q00534 | Uniprot Accession |
ENSG00000105810 | Ensembl Gene Id |
Interpro Acc | IPR002290 |
Uniprot Status | Swiss-Prot |
Interpro Type | Domain |
KINASE, DRUGGABLE GENOME |
CDK6 | Gene Symbol |
Target Class | Enzymes |
Target Subclass | EC:2.7.11.22 |
CDK6 | Display Id |
ENSG00000105810 | Ensembl Gene Id |
CELL DIVISION PROTEIN KINASE 6 (EC 2.7.1.37) (SERINE/THREONINE-PROTEIN KINASE PLSTIRE). [SOURCE:UNIPROT/SWISSPROT;ACC:Q00534] | Description |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
1021 | Entrez Gene ID |
CancerCommons Reported Gene Name | CDK4/6 |
1021 | Entrez Gene ID |
12 | CIViC Gene ID |
DRUG RESISTANCE |
CDK6 | Gene Symbol |
1021 | Entrez Gene Id |
CDK6 | MyCancerGenome Gene Symbol |
CDK 1,2,4,5,6,7,9 (pan-CDK) | MyCancerGenome Reported Gene Name |
CDKN6 | GENE_SYMBOL |
CDK6 | GENE_SYMBOL |
Cyclin-dependent kinase 6 | UNIPROT |
ENSG00000105810 | Gene Symbol |
CDK6 | Ensembl Id |
DRUGGABLE GENOME |
CDKN6 | GO Gene Synonym |
TUMOR SUPPRESSOR |
CDK6 | Gene Symbol |
CLINICALLY ACTIONABLE |
1021 | Gene ID |
PLSTIRE | dGene Synonym |
KINASE, SERINE THREONINE KINASE |
CDK6 | TTD Gene Abbreviation |
T89361 | TTD Target ID |
Cyclin-dependent kinase 6 | Gene Name |
Q00534 | UniProt ID |
KINASE |
CLINICALLY ACTIONABLE |
CLINICALLY ACTIONABLE |
CLINICALLY ACTIONABLE |
CLINICALLY ACTIONABLE |